<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04193709</url>
  </required_header>
  <id_info>
    <org_study_id>19.1124</org_study_id>
    <nct_id>NCT04193709</nct_id>
  </id_info>
  <brief_title>Recovery of Bladder and Sexual Function After Human Spinal Cord Injury</brief_title>
  <official_title>Effects of Activity-Dependent Plasticity on Recovery of Bladder and Sexual Function After Human Spinal Cord Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Louisville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Louisville</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will incorporate critical cross viscero-visceral intersystem interactions to 1)
      investigate in a controlled laboratory setting and then with mobile at-home monitoring the
      extent, severity, and frequency of occurrence of autonomic dysreflexia with respect to daily
      bladder and bowel function, in conjunction with identifying potential underlying mechanisms
      by examining urinary biomarkers for several specific vasoactive hormones, and 2) to regulate
      cardiovascular function therapeutically as part of bladder and bowel management using spinal
      cord epidural stimulation.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 4, 2021</start_date>
  <completion_date type="Anticipated">January 3, 2027</completion_date>
  <primary_completion_date type="Anticipated">January 3, 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Cross-sectional and observational (Arm 1) Prospective, cohort, and interventional (Arm 2).</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in systolic blood pressure over a 24 hour period after 80 sessions (6 months)</measure>
    <time_frame>Baseline, 80 sessions (6 months)</time_frame>
    <description>We will record systolic blood pressure every five minutes over a 24 hour period using a 24-hour blood pressure monitor</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in bladder capacity after 80 sessions (6 months)</measure>
    <time_frame>Baseline, 80 sessions (6 months)</time_frame>
    <description>Using urodynamics we will measure bladder capacity in mL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in detrusor pressure after 80 sessions (6 months)</measure>
    <time_frame>Baseline, 80 sessions (6 months)</time_frame>
    <description>Using urodynamics we will measure detrusor pressure in cmH2O.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in mean resting anal pressure after 80 sessions (6 months)</measure>
    <time_frame>Baseline, 80 sessions (6 months)</time_frame>
    <description>Using anorectal manometry will will measure mean resting anal pressure in mmHg.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in mean squeeze pressure after 80 sessions (6 months)</measure>
    <time_frame>Baseline, 80 sessions (6 months)</time_frame>
    <description>Using anorectal manometry we will measure mean squeeze pressure in mmHg.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Urinary Bladder, Neurogenic</condition>
  <condition>Blood Pressure</condition>
  <condition>Autonomic Dysreflexia</condition>
  <condition>Bowel Incontinence</condition>
  <arm_group>
    <arm_group_label>Measure symptomatic indices of autonomic dysreflexia</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The purpose of this arm is to systematically measure symptomatic indices of autonomic nervous system activation and corresponding cardiovascular changes in persons with spinal cord injuries during bladder filling and bowel stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cardiovascular spinal cord epidural stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The purpose of this arm is to use spinal cord epidural stimulation for maintenance of blood pressure and heart rate in the lab during cystometry (bladder filling) and anorectal filling (bowel distension) and in the at-home setting for maintenance of normative blood pressure and heart rate that can be triggered from bladder filling and during bowel evacuation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Spinal Cord Epidural Stimulation</intervention_name>
    <description>For arm 2, optimal stimulation parameters (cathode/anode configuration, stimulation frequency and voltage; placement of electrode from L1 to S1) will be identified for blood pressure and bladder pressure to achieve a bladder capacity in the target normative range of 400-450 mLs. Spinal cord epidural stimulation will then be used in a controlled lab setting for the regulation of blood pressure and heart rate to maintain normative values (target systolic pressure of 110-120 mmHg) and bladder pressure below 10 cmH2O during bladder filling up to the targeted capacity (fill volume of 400 mLs).</description>
    <arm_group_label>Cardiovascular spinal cord epidural stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Arm 1 Inclusion Criteria:

          -  At least 18 years of age;

          -  AIS A to D;

          -  Neurogenic bladder and bowel dysfunction;

          -  Stable medical condition

        Arm 2 Inclusion Criteria:

          -  At least 18 years of age;

          -  AIS A to D;

          -  Neurogenic bladder and bowel dysfunction;

          -  Use of intermittent catheterization for bladder emptying;

          -  Prior implantation of a Medtronic scES array

        Arms 1 and 2 Exclusion Criteria:

          -  Prior Botox injections of the bladder and/or bladder augmentation surgery;

          -  Colostomy bag,

          -  Ventilator dependent;

          -  Any implanted pump (i.e. Baclofen pump, pain pump, etc.);

          -  Pregnant at the time of enrollment or planning to become pregnant during the time
             course of the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Charles Hubscher, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Louisville</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charles Hubscher, PhD</last_name>
    <phone>502-852-3058</phone>
    <email>charles.hubscher@louisville.edu</email>
  </overall_contact>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>December 4, 2019</study_first_submitted>
  <study_first_submitted_qc>December 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Louisville</investigator_affiliation>
    <investigator_full_name>Charles Hubscher</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fecal Incontinence</mesh_term>
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Autonomic Dysreflexia</mesh_term>
    <mesh_term>Urinary Bladder, Neurogenic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

